Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stern, M. B.
Right arrow Articles by Grossman, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stern, M. B.
Right arrow Articles by Grossman, R. I.
NEUROLOGY 1989;39:1524
© 1989 American Academy of Neurology

Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes

M. B. Stern, MD, B. H. Braffman, MD, B. E. Skolnick, PhD, H. I. Hurtig, MD and R. I. Grossman, MD

From the Movement Disorder Center, Department of Neurology (Drs. Stern, Skolnick, and Hurtig), Graduate Hospital, and the Departments of Neurology (Drs. Stem and Hurtig) and Neuroradiology (Drs. Braffman and Grossman), University of Pennsylvania School of Medicine, Philadelphia, PA.

High field strength magnetic resonance imaging (MRI) provides a noninvasive means of evaluating patients with parkinsonism. Using strict clinical criteria, we began a prospective study of patients with Parkinson's disease (PD) and parkinsonian syndromes (PS) including progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and atypical parkinsonism (ATYP). We detected moderate to severe putaminal hypointensity more frequently in PS than in PD and controls, although putaminal hypointensity did not distinguish between MSA, PSP, or ATYP. Signal intensity in the lateral substantia nigra did not differ significantly among patients with PD, PS, or controls and was therefore not a useful MRI marker. Pars compacta width was significantly narrower in both PD and PS. Subcortical and periventricular hyperintense foci were more abundant in PD and PS than controls. Atrophy of the brainstem occurred only in patients with PS.

Address correspondence and reprint requests to Dr. Stern, Graduate Hospital, Department of Neurology, 18th & Lombard Streets, Philadelphia, PA 19146.

Supported in part by NIH grant #NS14867–10 and NIA giant #1-R01-AG05583.

Presented in part at the fortieth annual meeting of the American Academy of Neurology, Cincinnati, OH, April 1988.

Received August 16, 1988. Accepted for publication in final form May 4, 1989.




This article has been cited by other articles:


Home page
NeurologyHome page
L. I. Golbe
Early diagnosis of progressive supranuclear palsy: Bucking the odds
Neurology, November 25, 2008; 71(22): 1754 - 1755.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
D. Dormont, D.J. Seidenwurm, and for the Expert Panel on Neurologic Imaging
Dementia and Movement Disorders
AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 204 - 206.
[Full Text] [PDF]


Home page
BrainHome page
A. Lannuzel, G. U. Hoglinger, S. Verhaeghe, L. Gire, S. Belson, M. Escobar-Khondiker, P. Poullain, W. H. Oertel, E. C. Hirsch, B. Dubois, et al.
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Brain, March 1, 2007; 130(3): 816 - 827.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. C. Paviour, S. L. Price, M. Jahanshahi, A. J. Lees, and N. C. Fox
Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy
Brain, April 1, 2006; 129(4): 1040 - 1049.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. C. Paviour, S. L. Price, J. M. Stevens, A. J. Lees, and N. C. Fox
Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy
Neurology, February 22, 2005; 64(4): 675 - 679.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A. Righini, A. Antonini, R. De Notaris, E. Bianchini, N. Meucci, G. Sacilotto, M. Canesi, D. De Gaspari, F. Triulzi, and G. Pezzoli
MR Imaging of the Superior Profile of the Midbrain: Differential Diagnosis between Progressive Supranuclear Palsy and Parkinson Disease
AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 927 - 932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
H. Oikawa, M. Sasaki, Y. Tamakawa, S. Ehara, and K. Tohyama
The Substantia Nigra in Parkinson Disease: Proton Density-Weighted Spin-Echo and Fast Short Inversion Time Inversion-Recovery MR Findings
AJNR Am. J. Neuroradiol., November 1, 2002; 23(10): 1747 - 1756.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. Watanabe, Y. Saito, S. Terao, T. Ando, T. Kachi, E. Mukai, I. Aiba, Y. Abe, A. Tamakoshi, M. Doyu, et al.
Progression and prognosis in multiple system atrophy: An analysis of 230 Japanese patients
Brain, May 1, 2002; 125(5): 1070 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
K. Bhattacharya, D. Saadia, B. Eisenkraft, M. Yahr, W. Olanow, B. Drayer, and H. Kaufmann
Brain Magnetic Resonance Imaging in Multiple-System Atrophy and Parkinson Disease: A Diagnostic Algorithm
Arch Neurol, May 1, 2002; 59(5): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias
J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166.
[Abstract] [PDF]


Home page
BrainHome page
J. M. Graham, M. N. J. Paley, R. A. Grunewald, N. Hoggard, and P. D. Griffiths
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence
Brain, December 1, 2000; 123(12): 2423 - 2431.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Schrag, C. D. Good, K. Miszkiel, H. R. Morris, C. J. Mathias, A. J. Lees, and N. P. Quinn
Differentiation of atypical parkinsonian syndromes with routine MRI
Neurology, February 8, 2000; 54(3): 697 - 697.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. Kraft, J. Schwarz, C. Trenkwalder, T. Vogl, T. Pfluger, and W. H. Oertel
The Combination of Hypointense and Hyperintense Signal Changes on T2-Weighted Magnetic Resonance Imaging Sequences: A Specific Marker of Multiple System Atrophy?
Arch Neurol, February 1, 1999; 56(2): 225 - 228.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Winikates and J. Jankovic
Clinical Correlates of Vascular Parkinsonism
Arch Neurol, January 1, 1999; 56(1): 98 - 102.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Schrag, D Kingsley, C Phatouros, C J Mathias, A J Lees, S E Daniel, and N P Quinn
Clinical usefulness of magnetic resonance imaging in multiple system atrophy
J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 65 - 71.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
P. Ryvlin, E. Broussolle, H. Piollet, F. Viallet, Y. Khalfallah, and G. Chazot
Magnetic Resonance Imaging Evidence of Decreased Putamenal Iron Content in Idiopathic Parkinson's Disease
Arch Neurol, June 1, 1995; 52(6): 583 - 588.
[Abstract] [PDF]


Home page
Arch NeurolHome page
P. Piccini, N. Pavese, R. Canapicchi, C. Paoli, P. Del Dotto, M. Puglioli, G. Rossi, and U. Bonuccelli
White Matter Hyperintensities in Parkinson's Disease: Clinical Correlations
Arch Neurol, February 1, 1995; 52(2): 191 - 194.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.